Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Fluoroquinolones in children with fever and neutropenia: a systematic review of prospective trials.

Sung L, Manji A, Beyene J, Dupuis LL, Alexander S, Phillips R, Lehrnbecher T.

Pediatr Infect Dis J. 2012 May;31(5):431-5. doi: 10.1097/INF.0b013e318245ab48. Review.

PMID:
22189521
2.

Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropenia.

Cooper MR, Durand CR, Beaulac MT, Steinberg M.

Ann Pharmacother. 2011 Sep;45(9):1094-102. doi: 10.1345/aph.1Q147. Epub 2011 Aug 23. Review.

PMID:
21862714
3.

A meta-analysis of antipseudomonal penicillins and cephalosporins in pediatric patients with fever and neutropenia.

Manji A, Lehrnbecher T, Dupuis LL, Beyene J, Sung L.

Pediatr Infect Dis J. 2012 Apr;31(4):353-8. doi: 10.1097/INF.0b013e318242590e.

PMID:
22173145
4.

A systematic review and meta-analysis of anti-pseudomonal penicillins and carbapenems in pediatric febrile neutropenia.

Manji A, Lehrnbecher T, Dupuis LL, Beyene J, Sung L.

Support Care Cancer. 2012 Oct;20(10):2295-304. doi: 10.1007/s00520-011-1333-3. Epub 2011 Dec 6. Review.

PMID:
22138849
5.

Oral gatifloxacin in the outpatient treatment of children with cancer fever and neutropenia.

Petrilli A, Altruda Carlesse F, Alberto Pires Pereira C.

Pediatr Blood Cancer. 2007 Oct 15;49(5):682-6.

PMID:
17253640
6.

First-day step-down to oral outpatient treatment versus continued standard treatment in children with cancer and low-risk fever in neutropenia. A randomized controlled trial within the multicenter SPOG 2003 FN study.

Brack E, Bodmer N, Simon A, Leibundgut K, Kühne T, Niggli FK, Ammann RA.

Pediatr Blood Cancer. 2012 Sep;59(3):423-30. doi: 10.1002/pbc.24076. Epub 2012 Jan 23.

PMID:
22271702
8.

Outpatient and oral antibiotic management of low-risk febrile neutropenia are effective in children--a systematic review of prospective trials.

Manji A, Beyene J, Dupuis LL, Phillips R, Lehrnbecher T, Sung L.

Support Care Cancer. 2012 Jun;20(6):1135-45. doi: 10.1007/s00520-012-1425-8. Epub 2012 Mar 9. Review.

PMID:
22402749
9.

Colony-stimulating factors for chemotherapy-induced febrile neutropenia: a meta-analysis of randomized controlled trials.

Clark OA, Lyman GH, Castro AA, Clark LG, Djulbegovic B.

J Clin Oncol. 2005 Jun 20;23(18):4198-214.

PMID:
15961767
10.

Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trials.

Vidal L, Paul M, Ben dor I, Soares-Weiser K, Leibovici L.

J Antimicrob Chemother. 2004 Jul;54(1):29-37. Epub 2004 Jun 16. Review.

PMID:
15201227
11.

Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients.

Mullen CA.

Pediatr Infect Dis J. 2003 Dec;22(12):1138-42. Review.

PMID:
14688588
12.
13.

Once daily, oral, outpatient quinolone monotherapy for low-risk cancer patients with fever and neutropenia: a pilot study of 40 patients based on validated risk-prediction rules.

Rolston KV, Manzullo EF, Elting LS, Frisbee-Hume SE, McMahon L, Theriault RL, Patel S, Benjamin RS.

Cancer. 2006 Jun 1;106(11):2489-94.

14.

Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.

Paganini H, Rodriguez-Brieshcke T, Zubizarreta P, Latella A, Firpo V, Casimir L, Armada A, Fernández C, Cáceres E, Debbag R.

Cancer. 2001 Apr 15;91(8):1563-7.

PMID:
11301406
15.

Do fluoroquinolones commonly cause arthropathy in children?

Forsythe CT, Ernst ME.

CJEM. 2007 Nov;9(6):459-62. Review.

PMID:
18072993
16.

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.

Freifeld A, Marchigiani D, Walsh T, Chanock S, Lewis L, Hiemenz J, Hiemenz S, Hicks JE, Gill V, Steinberg SM, Pizzo PA.

N Engl J Med. 1999 Jul 29;341(5):305-11.

17.

Strategies for Empiric Management of Pediatric Fever and Neutropenia in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review of Randomized Trials.

Robinson PD, Lehrnbecher T, Phillips R, Dupuis LL, Sung L.

J Clin Oncol. 2016 Jun 10;34(17):2054-60. doi: 10.1200/JCO.2015.65.8591. Epub 2016 Mar 28. Review.

PMID:
27022114
18.

Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.

Paganini H, Gómez S, Ruvinsky S, Zubizarreta P, Latella A, Fraquelli L, Iturres AS, Casimir L, Debbag R.

Cancer. 2003 Apr 1;97(7):1775-80.

19.

Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer.

Chuang YY, Hung IJ, Yang CP, Jaing TH, Lin TY, Huang YC.

Pediatr Infect Dis J. 2002 Mar;21(3):203-9.

PMID:
12005083
20.

A prospective multicenter study of microbiologically defined infections in pediatric cancer patients with fever and neutropenia: Swiss Pediatric Oncology Group 2003 fever and neutropenia study.

Agyeman P, Kontny U, Nadal D, Leibundgut K, Niggli F, Simon A, Kronenberg A, Frei R, Escobar H, Kühne T, Beck-Popovic M, Bodmer N, Ammann RA.

Pediatr Infect Dis J. 2014 Sep;33(9):e219-25. doi: 10.1097/INF.0000000000000326.

Supplemental Content

Support Center